Furthermore, NKA α2 shRNA restored the balance of pro- and anti- inflammatory cytokines as well as decreased the TLR4, MyD88, and NF-κB p65 expression in the PVN during the development of hypertension. The gene discussed is MYD88; the disease is hypertensive disorder.